Allyson Guidroz - Aug 24, 2023 Form 3 Insider Report for AMEDISYS INC (AMED)

Role
Chief Accounting Officer
Signature
Jennifer Guckert Griffin, pursuant to a power of attorney
Stock symbol
AMED
Transactions as of
Aug 24, 2023
Transactions value $
$0
Form type
3
Date filed
9/5/2023, 08:56 PM
Next filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AMED Common Stock 5.13K Aug 24, 2023 Direct F1
holding AMED Common Stock 1.5 Aug 24, 2023 By 401(k) Plan F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AMED Stock Option (Right to Buy) Aug 24, 2023 Common Stock 272 $95.76 Direct F3
holding AMED Stock Option (Right to Buy) Aug 24, 2023 Common Stock 640 $132.41 Direct F4
holding AMED Stock Option (Right to Buy) Aug 24, 2023 Common Stock 563 $214.74 Direct F5
holding AMED Stock Option (Right to Buy) Aug 24, 2023 Common Stock 590 $264.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 117 performance-based restricted stock units tied to a performance metric for the 2020 fiscal year, which was certified as achieved and subject to further time-based vesting on July 25,2024; 118 time-based restricted stock units ("RSUs") that vest on July 25, 2024; 60 time-based RSUs that vest on July 25, 2025; 406 time-based RSUs that vest on each of June 1, 2024, 2025 and 2026; 647 time-based RSUs that vest on each of May 3, 2024, 2025 and 2026; and 648 time-based RSUs that vest on May 3, 2027, assuming in each case that the Reporting Person remains continuously employed by the Issuer on each such vesting date.
F2 The information in this report is based on a plan statement dated as of June 30, 2023.
F3 All 272 stock options are fully vested and immediately exercisable.
F4 All 640 stock options are fully vested and immediately exercisable.
F5 The stock options are subject to time-based vesting conditions. 422 stock options are fully vested and immediately exercisable, and the remaining 141 stock options will vest on July 25, 2024, provided that the Reporting Person remains continuously employed by the Issuer on such date.
F6 The stock options are subject to time-based vesting conditions. 295 stock options are fully vested and immediately exercisable, 147 stock options will vest on July 25, 2024, and 148 stock options will vest on July 25, 2025, provided that the Reporting Person remains continuously employed by the Issuer on each such date.

Remarks:

Exhibit 24.1 - Power of Attorney